LAG3 anticorps (AA 70-99) (Atto 488)
Aperçu rapide pour LAG3 anticorps (AA 70-99) (Atto 488) (ABIN2612231)
Antigène
Voir toutes LAG3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 70-99
-
Specificité
- Recognizes the 30 aa extra-loop of the first N-terminal D1 domain of human LAG-3.
-
Purification
- Protein A purified from tissue culture supernatant
-
Immunogène
-
Synthetic peptide corresponding to 30 aa (GPPAAAPGHPLAPGPHPAAPSSWGPRPRRY) from the first N-terminal D1 domain of human LAG-3 (lymphocyte activation gene-3). Percent identity by BLAST analysis: Human (100%), Gorilla (93%), Gibbon (90%), Monkey (83%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG1
-
-
-
-
Indications d'application
-
Approved: Flo (1:100), Func, ICC, IHC, IHC-Fr, IP, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. Flow Cytometry - 1:100. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Do not freeze.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 4°C. Do not freeze. Protect from light.
-
-
- LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
-
Autre désignation
- LAG3
-
Sujet
-
Name/Gene ID: LAG3
Synonyms: LAG3, CD223 antigen, LAG-3, Protein FDC, CD223, FDC, Lymphocyte-activation gene 3 -
ID gène
- 3902
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Antigène
-